Cooley advised Kriya on the fundraising. Kriya Therapeutics, Inc. announced the addition of over $150 million in capital committed as part of its Series C Financing,...
Kriya’s $150 Million Series C Extension
Kriya Therapeutics’ $270 Million Series C Financing Round
Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing...
Alpargatas’ $475 Million Series B Investment in Rothy’s
Mayer Brown represented Alpargatas S.A. in the transaction while Cooley advised Rothy. Alpargatas S.A., a Brazil-based, global footwear company creator of the famous flip flop “Havaianas,”...